PTC
MRVI icon

Private Trust Company’s Maravai LifeSciences MRVI Stock Holding History

Private Trust Company’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-436
Closed -$3.62K – 2380
2024
Q3 		$3.62K Hold
436
– – ﹤0.01% 2052
2024
Q2 		$3.12K Buy
436
+118
+37% +$1.02K ﹤0.01% 2070
2024
Q1 		$2.76K Hold
318
– – ﹤0.01% 2064
2023
Q4 		$2.08K Sell
318
-1,009
-76% -$6.52K ﹤0.01% 2124
2023
Q3 		$13.3K Hold
1,327
– – ﹤0.01% 1497
2023
Q2 		$16.5K Buy
1,327
+1,141
+613% +$15.4K ﹤0.01% 1434
2023
Q1 		$2.61K Sell
186
-22
-11% -$316 ﹤0.01% 2027
2022
Q4 		$3K Buy
+208
New +$3.27K ﹤0.01% 1942

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Private Trust Company's MRVI Position: Q4 2024 in Review

Private Trust Company sold out of Maravai LifeSciences (MRVI) in Q4 2024, closing a stake of 436 shares — an estimated $3.62K sold.

Private Trust Company first reported a position in MRVI in Q4 2022 and held it in 8 quarters. The position peaked at $16.5K in Q2 2023. 185 funds tracked by Wall St. Rank hold MRVI as of Q4 2024.

  • Private Trust Company reported no remaining Maravai LifeSciences position as of Q4 2024 after selling out during the quarter.
  • Private Trust Company sold 436 Maravai LifeSciences shares in Q4 2024, an estimated $3.62K.
  • Private Trust Company first reported a position in Maravai LifeSciences in Q4 2022 and held it in 8 quarters.
  • Private Trust Company's Maravai LifeSciences position peaked at $16.5K in Q2 2023.
  • 185 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2024.

Based on Private Trust Company's 13F filing for Q4 2024, filed 5 Feb 2025.